Skip to main content
SpringerLink
Log in

Authors’ Reply to Hays: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”

  • Letter to the Editor
  • Published:
Applied Health Economics and Health Policy Aims and scope Submit manuscript

The Original Article was published on 23 March 2020

The Original Research Article was published on 20 September 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hays J. Comment on: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”. Appl Health Econ Health Policy. 2020. https://doi.org/10.1007/s40258-020-00574-9.

    Article  PubMed  Google Scholar 

  2. Mott DJ, Hampson G, Llewelyn MJ, Mestre-Ferrandiz J, Hopkins MM. A Multinational European Study of patient preferences for novel diagnostics to manage antimicrobial resistance. Appl Health Econ Health Policy. 2020;18:69–79. https://doi.org/10.1007/s40258-019-00516-0.

    Article  PubMed  Google Scholar 

  3. Little P, Moore M, Kelly J, Williamson I, Leydon G, McDermott L, Mullee M, Stuart B, On behalf of the PIPS Investigators. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ. 2014;348:g1606. https://doi.org/10.1136/bmj.g1606.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gharbi M, Drysdale JH, Lishman H, Goudie R, Molokhia M, Johnson AP, Holmes AH, Aylin P. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ. 2019. https://doi.org/10.1136/bmj.l525.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Vik I, Bollestad M, Grude N, Bærheim A, Damsgaard E, Neumark T, Bjerrum L, Cordoba G, Olsen IC, Lindbæk M. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women—a double-blind, randomized non-inferiority trial. PLoS Med. 2018;15:e1002569. https://doi.org/10.1371/journal.pmed.1002569.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pedersen LB, Kjær T, Kragstrup J, Gyrd-Hansen D. Does the inclusion of a cost attribute in forced and unforced choices matter? J Choice Model. 2011;4:88–109. https://doi.org/10.1016/S1755-5345(13)70044-7.

    Article  Google Scholar 

  7. Hamilton WL, Pires S-M, Lippett S, Gudka V, Cross ELA, Llewelyn MJ. The impact of diagnostic microbiology on de-escalation of antimicrobial therapy in hospitalised adults. BMC Infect Dis. 2020;20:102. https://doi.org/10.1186/s12879-020-4823-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, UK

    David J. Mott, Grace Hampson & Jorge Mestre-Ferrandiz

  2. Brighton and Sussex Medical School, Brighton, UK

    Martin J. Llewelyn

  3. Independent Economics Consultant, Madrid, Spain

    Jorge Mestre-Ferrandiz

  4. Science Policy Research Unit, University of Sussex Business School, Jubilee Building, Falmer, Brighton, UK

    Michael M. Hopkins

Authors
  1. David J. Mott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grace Hampson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin J. Llewelyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jorge Mestre-Ferrandiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael M. Hopkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Mott.

Ethics declarations

Funding

No sources of funding were used to prepare this response.

Conflicts of Interest

DJM and GH are employees of the Office of Health Economics, which is a registered charity that receives funding from a variety of sources, including the Association of the British Pharmaceutical Industry. MJL, JM-F and MMH have no conflicts of interest that are relevant to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mott, D.J., Hampson, G., Llewelyn, M.J. et al. Authors’ Reply to Hays: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”. Appl Health Econ Health Policy 18, 459–460 (2020). https://doi.org/10.1007/s40258-020-00573-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40258-020-00573-w

Search

Navigation